VOICE trial: Microbicide gel may have stopped two out of three HIV infections – in the women who used it
Improved school attendance credited with reducing HIV infections among teenage girls in Uganda
Strategies to improve male partner involvement in microbicide research needed
Injectable rilpivirine shows promise in phase I trials – but may work better for anal than vaginal sex
Tenofovir gel use associated with lower HSV-2 risk in women
How does a ‘human rights based approach’ work out on the ground? Lessons from South Africa
Treatment of worm infections leads to increases in CD4 counts and haemoglobin and fall in viral load for HIV-positive women taking ART
Stigma, ambivalence and other priorities – explaining poor adherence to PrEP and vaginal microbicides
